Congratulations to the 2025-2026 TSCAP elected officers:
President: Joseph Shotwell, MD
President-Elect: Lisa Falls, MD
Secretary/Treasurer: Alcides Amador, MD
Immediate Past President: Andrew Diederich, MD
Councilor 2025-2028: Sarah Wakefield, MD
Councilor 2025-2028: Micah Knobles, MD
AACAP Delegate 2025-2028: Katherine Kerr, MD
8 AMA PRA Category 1 CreditsTM
with 3 of the Hours designated for Medical Ethics/Professional Responsibility
Saturday July 19, 2025
| 8:15 am – 8:30 am | Opening Remarks |
| 8:30 am – 9:30 am | Navigating Juvenile Justice: Challenges and Solutions Patrick Butler, MD |
| Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to: – Understand the basics of the Juvenile Justice System. – Identify common mental health issues among juveniles in the justice system (e.g., ADHD, anxiety, depression, PTSD). – Identify various therapeutic interventions and rehabilitation programs used to address mental health issues in youth. – Explore legal and ethical considerations. – Analyze the role of juvenile justice in prevention and rehabilitation. | |
| 9:30 am – 10:30 am | Adolescent Relationships in the Digital Age Jeffrey R. Temple, PhD |
| Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to: – Examine the impact of digital communication on adolescent health and behavior. – Explore digital literacy and healthy relationship skills. – Identify interventions that promote healthy relationship skills. | |
| 10:30 am – 10:50 am | Refreshment Break with Door Prize Drawings, Exhibitors, and Poster Session |
| 10:50 am – 11:50 am | Contemporary ADHD Management: Beyond the Stimulant Paradigm Jon Stevens, MD, MPH |
| Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to: – Differentiate Treatment Modalities: Recognize that while stimulants remain the cornerstone for ADHD treatment, nonstimulants (such as atomoxetine, viloxazine, and alpha-2 agonists) offer respectable efficacy with a safer profile and beneficial effects on comorbidities. – Evaluate Emerging Alternatives: Understand the potential role of off-label treatments – such as bupropion, orexin agonists (e.g., modafinil, armodafinil), and transcranial magnetic stimulation (TMS) – ad adjuncts or alternatives in select cases, particularly for patients with concerns about stimulant side effects or substance misuse. – Tailor Individualized Care: Apply clinical insights to optimize medication selection by integrating both established stimulant therapies and promising non-stimulant options based on patient-specific needs. | |
| 11:50 am – 12:10 pm | Refreshment Break with Door Prize Drawings, Exhibitors, and Poster Session |
| 12:10 pm – 1:10 pm | Legislative Luncheon |
| 1:10 pm – 3:10 pm | AI in Psychiatry: Opportunities, Risks, and Implementation – Darlene King, M.D. AI, Ethics and Legal Considerations in Medical Practice – Karin Zaner, JD |
| Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to: – Understand the landscape of AI and key terms relevant to existing and novel uses of AI in clinical care and in society. – Describe potential applications of AI in psychiatry, with a particular focus on understanding the risks and benefits of different uses. – Define and compare AI, generative AI, hallucinations, and other relevant AI terms and how they may apply to a physician’s practice of medicine. – Understand key points of current AMA guidance regarding AI, including heightened vigilance and human oversight, especially when clinical care decisions are impacted. – Discuss best practices when using AI in a physician’s practice of medicine, including complying with HIPAA and patient confidentiality obligations. | |
| 3:10 pm – 3:30 pm | Closing Remarks |
Sunday July 20, 2025
| 9:00 am – 9:15 am | Opening Remarks |
| 9:15 am – 10:15 am | Development and Screen Time: Research Guidelines and Practical Tips Sara Loftin, MS, LPC-S, RPT-S |
| Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to: – Identify statistics regarding screen time. – Summarize screen time literature. – Describe screen use guidelines and healthy habits. | |
| 10:15 am – 10:30 am | Refreshment Break |
| 10:30 am – 12:30 pm | Telepsychiatry: Clinical Best Practices, Key Legal & Regulatory Updates, and Ethical Considerations (Panel) Joseph Shotwell, MD; Lisa Falls, MD; Denise Baughn, MD; Angeline Trinh, MD; Alcides Amador, MD |
| Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to: – Identify federal and state COVID-19 pandemic flexibilities that facilitated telepsychiatry practice, distinguishing between permanent, temporary and expired ones. – Explain key videoconferencing etiquette techniques that help facilitate patient engagement and assessment. – Discuss clinical challenges and best practices in pediatric telepsychiatry. – Explore the impact of social determinants of health and digital access disparities on care via telepsychiatry. – Identify and navigate ethical dilemmas that are specific to telepsychiatry. | |
| 12:30 pm – 1:00 pm | Closing Remarks |
CME PROGRAM OBJECTIVES / TARGET AUDIENCE This live activity has been designed with didactic lectures supplemented with panel discussion, clinical vignettes, audiovisual presentations, case presentation and discussion in multiple educational sessions. The program is designed to provide its target audience of Child and Adolescent Psychiatrists, Adult Psychiatrists, Pediatricians and Primary Care Physicians with clinically relevant information to advance the physicians’ competence so that they may develop strategies to apply the knowledge, skills and judgement from the educational activity into their practice. Physicians often encounter patients that have both psychiatric and neurologic symptoms related to a single etiology. These conditions are inherently complex and often require additional considerations and collaboration between specialties. The objectives of this program aim to equip the attendees with the ability to better assess and care for patients with a variety of diagnoses, treatment options, and special needs.
IDENTIFIED PRACTICE GAPS / NEEDS ASSESSMENT TSCAP has incorporated into this CME activity the relevant educational needs concerning competence that underlie the professional practice gaps of our participants.
ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the Essential Areas accreditation requirements and policies of the Texas Medical Association (TMA) through the Joint Providership of the Texas Society of Psychiatric Physicians and the Texas Society of Child and Adolescent Psychiatry. TSPP is accredited by the TMA to provide continuing education for physicians.
CREDIT STATEMENT The Texas Society of Psychiatric Physicians designates this Live Activity for a maximum of eight (8) AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
MEDICAL ETHICS and/or PROFESSIONAL RESPONSIBILITY STATEMENT The Ethics Presentation: “AI, Ethics and Legal Considerations in Medical Practice” has been designated by the Texas Society of Psychiatric Physicians for a total of one (1) credit of education in medical ethics and/or professional responsibility. The Ethics Presentation: “Telepsychiatry: Clinical Best Practices, Key Legal & Regulatory Updates, and Ethical Considerations” has been designated by the Texas Society of Psychiatric Physicians for a total of two (2) credits of education in medical ethics and/or professional responsibility.
FACULTY AND PLANNERS DISCLOSURE POLICY In compliance with the ACCME/TMA Standards for Commercial Support of CME, to assure balance, independence, objectivity and scientific rigor in all of its CME activities, prior to the education activity being delivered to the learners, the Texas Society of Psychiatric Physicians implemented a mechanism to identify and resolve personal conflicts of interest from everyone who was in a position to control the content of the education activity. TSPP will disclose to learners the existence (or non-existence) of all relevant financial relationship(s) that the faculty and planners did (or did not) have with any ineligible companies concerned with the content of the educational presentation. Disclosure will occur prior to the presentation through written communication.
